Molecular ESR1 changes may signal symptomatic progression before imaging in metastatic breast cancer, supporting camizestrant for improved quality of life.

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

A new study adds to the research that night-shift work can be deadly, increasing breast cancer risk and speeding it's spread, ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

A study has found that people exercise regularly, quit smoking, and practice five other health strategies can improve their ...

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only 5%.

Disrupted sleep schedules may change breast tissue and immune function, helping aggressive breast cancer grow faster.

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer.

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...